Amundi
GMED icon

Amundi’s Globus Medical GMED Stock Holding History

Amundi’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.24M Sell
66,382
-8,138
-11% -$692K ﹤0.01% 1014
2026
Q1 		$6.42M Buy
74,520
+8,126
+12% +$729K ﹤0.01% 943
2025
Q4 		$5.8M Buy
+66,394
New +$5.04M ﹤0.01% 1004
2025
Q2 		– Sell
-25,714
Closed -$1.85M – 1874
2025
Q1 		$1.85M Buy
25,714
+25,710
+642,750% +$2.12M ﹤0.01% 1171
2024
Q4 		$346 Buy
+4
New +$315 ﹤0.01% 2127
2024
Q2 		– Sell
-51,290
Closed -$2.6M – 1971
2024
Q1 		$2.6M Buy
51,290
+3,060
+6% +$165K ﹤0.01% 1099
2023
Q4 		$2.6M Sell
48,230
-37,822
-44% -$1.84M ﹤0.01% 1128
2023
Q3 		$4.57M Sell
86,052
-120,071
-58% -$6.71M ﹤0.01% 1000
2023
Q2 		$12M Buy
206,123
+155,621
+308% +$8.87M 0.01% 804
2023
Q1 		$2.89M Buy
50,502
+13,072
+35% +$838K ﹤0.01% 1097
2022
Q4 		$2.75M Buy
37,430
+28,071
+300% +$1.91M ﹤0.01% 1132
2022
Q3 		$585K Buy
+9,359
New +$564K ﹤0.01% 1325

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Amundi's GMED Position: Q2 2026 in Review

Amundi reduced its Globus Medical (GMED) stake by 11% in Q2 2026, selling an estimated $692K and leaving 66,382 shares worth $5.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1014.

Amundi first reported a position in GMED in Q3 2022 and has held it in 12 quarters since. The position peaked at $12M in Q2 2023. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Amundi held 66,382 shares of Globus Medical worth $5.24M as of Q2 2026.
  • Amundi sold 8,138 Globus Medical shares in Q2 2026, an estimated $692K.
  • Globus Medical made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1014 holding.
  • Amundi first reported a position in Globus Medical in Q3 2022 and has held it in 12 quarters since.
  • Amundi's Globus Medical position peaked at $12M in Q2 2023.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.